Toll Free: 1-888-928-9744

Antiviral Drugs Market Analysis By Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitor, Protease Inhibitor), By Application ((HIV, Hepatitis, HSV, Influenza), By Type (Generic, Branded)), And Segment Forecasts, 2014 - 2025

Published: Feb 10, 2017 | Pages: 85 | Publisher: Grand View Research | Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global antiviral drugs market is expected to reach a value of USD 69.2 billion by 2025, based on a new report by Grand View Research, Inc. According to the WHO, cases of viral infections increase by more than 1 million each year with around 357 million patients already suffering from one of the four Sexually Transmitted Infections (STIs), such as Acquired Immunodeficiency Syndrome (AIDS).

Introduction of efficient antiviral drugs with benefits such as rapid action, increased sensitivity, and lower adverse effects is expected to serve this market as a high-impact rendering driver over the forecast period. For instance, Gilead Sciences introduced an FDA-approved drug-Genvoya-in 2016 for treatment of AIDS patients who have previously faced adverse effects, such as bone loss and kidney dysfunction.

Low levels of hygiene, growing geriatric population, and increasing awareness through government campaigns are other drivers resulting in high acceptance of antiviral drugs in developing countries.

Further Key Findings from the Study Suggest:

Reverse transcriptase inhibitors held the largest share by mechanism of action owing to availability of wide range of product portfolio and presence of new molecules in clinical trials

Nucleotide inhibitors are estimated to grow at lucrative rate due to introduction of blockbuster molecules for treatment of Hepatitis C Virus (HCV) infections

Generic drugs are anticipated to witness significant CAGR of over 7.0% over the forecast period as result of patent expiry of blockbuster drugs used for treatment of HIV and HCV

Branded drugs will hold dominant position in 2025 by drug type due to brand loyalty of healthcare professions despite patent expiration and high price associated with these molecules

HIV/AIDS held the dominant share in 2015. High prevalence of HIV infections and presence of favorable government initiatives for curbing them are key factors for high revenue of this segment

Hepatitis on the other hand is anticipated to witness flourishing growth over the forecast period owing to introduction of new molecules and approval of novel combination treatments

North America was the dominant regional market in 2015. High market share is associated with established R&D infrastructure and growing drug development initiatives

Asia Pacific region is anticipated to exhibit fastest regional growth. Local presence of key generic players and growing healthcare infrastructure in this region are key factors for growth

Some of the key players of this market include Gilead Sciences; F. Hoffmann-La Roche AG; GlaxoSmithKline; Bristol-Myers-Squibb; AbbVie; Johnson & Johnson; and Merck & Co. Other generic players in this market are Aurobindo Pharma, Cipla, and Dr Reddy's 
 Table of Contents

Chapter 1 Research Methodology & Scope
                     1.1 Information Procurement
                          1.1.1 Purchased database:
                          1.1.2 GVR's internal database
                     1.2 Research Methodology
                     1.3 Geographic scope & assumptions
                     1.4 Region-wise market calculation
                          1.4.1 Region-wise market: Base estimates
                          1.4.2 Global market: CAGR calculation
                     1.5 Region-based segment share calculation
                     1.6 List of Secondary Sources
Chapter 2 Executive Summary
                     2.1 Market Snapshot
Chapter 3 Antiviral Drugs Market Variables, Trends & Scope
                     3.1 Market segmentation& scope
                          3.1.1 Market Driver Analysis
                               3.1.1.1 Growing geriatric population base
                               3.1.1.2 Growing prevalence of target diseases
                               3.1.1.3 Increasing R&D expenditure
                          3.1.2 Market restraint analysis
                               3.1.2.1 High cost
                          3.1.3 Stringent regulatory scenario
                     3.2 Penetration & growth prospect mapping
                     3.3 Antiviral Drugs- SWOT Analysis, By Factor (political & legal, economic and technological)
                     3.4 Industry Analysis - Porter's
Chapter 4 Antiviral Drugs Market: Mechanism of Action Estimates & Trend Analysis
                     4.1 Antiviral drugs market: Mechanism of action movement analysis
                     4.2 Nucleotide polymerase inhibitor
                          4.2.1 Nucleotide polymerase inhibitor market, 2014 - 2025 (USD Billion)
                     4.3 Reverse transcriptase inhibitors
                          4.3.1 Reverse transcriptase inhibitors market, 2014 - 2025 (USD Billion)
                     4.4 Protease inhibitors
                          4.4.1 Protease inhibitors market, 2014 - 2025 (USD Billion)
                     4.5 Others
                          4.5.1 Others market, 2014 - 2025 (USD Billion)
Chapter 5 Antiviral Drugs Market: Type Estimates & Trend Analysis
                     5.1 Antiviral drugs market: Type movement analysis
                     5.2 Generic drugs
                          5.2.1 Generic drugs market, 2014 - 2025 (USD Billion)
                     5.3 Branded drugs
                          5.3.1 Branded drugs market, 2014 - 2025 (USD Billion)
Chapter 6 Antiviral Drugs Market: Application Estimates & Trend Analysis
                     6.1 Antiviral drugs market: Application movement analysis
                     6.2 HIV
                          6.2.1 HIV market, 2014 - 2025 (USD Billion)
                     6.3 Hepatitis market
                          6.3.1 Hepatitis market market, 2014 - 2025 (USD Billion)
                     6.4 Herpes virus
                          6.4.1 Herpes virus market, 2014 - 2025 (USD Billion)
                     6.5 Influenza
                          6.5.1 Influenza market, 2014 - 2025 (USD Billion)
                     6.6 Others
                          6.6.1 Others market, 2014 - 2025 (USD Billion)
Chapter 7 Antiviral Drugs Market: Regional Estimates & Trend Analysis, by Application
                     7.1 Antiviral drugs market share by region, 2015 & 2025
                     7.2 North America
                          7.2.1 North America antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.2.2 U.S
                               7.2.2.1 U.S antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.2.3 Canada
                               7.2.3.1 Canada antiviral drugs market, 2014 - 2025 (USD Billion)
                     7.3 Europe
                          7.3.1 Europe antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.3.2 UK
                               7.3.2.1 UK antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.3.3 Germany
                               7.3.3.1 Germany antiviral drugs market, 2014 - 2025 (USD Billion)
                     7.4 Asia Pacific
                          7.4.1 Asia Pacific antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.4.2 Japan
                               7.4.2.1 Japan antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.4.3 China
                               7.4.3.1 China antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.4.4 India
                               7.4.4.1 India antiviral drugs market, 2014 - 2025 (USD Billion)
                     7.5 Latin America
                          7.5.1 Latin America antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.5.2 Brazil
                               7.5.2.1 Brazil antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.5.3 Mexico
                               7.5.3.1 Mexico antiviral drugs market, 2014 - 2025 (USD Billion)
                     7.6 MEA
                          7.6.1 MEA antiviral drugs market, 2014 - 2025 (USD Billion)
                          7.6.2 South Africa
                               7.6.2.1 South Africa antiviral drugs market, 2014 - 2025 (USD Billion)
Chapter 8 Competitive Landscape
                     8.1 Strategy Framework
                     8.2 Market Participation Categorization
                     8.3 Company Profiles
                          8.3.1 Gilead Sciences
                               8.3.1.1 Company overview
                               8.3.1.2 Financial performance
                               8.3.1.3 Product benchmarking
                               8.3.1.4 Strategic initiatives
                          8.3.2 F. Hoffmann-La Roche AG
                               8.3.2.1 Company overview
                               8.3.2.2 Financial performance
                               8.3.2.3 Product benchmarking
                               8.3.2.4 Strategic initiatives
                          8.3.3 GlaxoSmithKline
                               8.3.3.1 Company overview
                               8.3.3.2 Financial performance
                               8.3.3.3 Product benchmarking
                               8.3.3.4 Strategic initiatives
                          8.3.4 Bristol-Myers-Squibb
                               8.3.4.1 Company overview
                               8.3.4.2 Financial performance
                               8.3.4.3 Product benchmarking
                               8.3.4.4 Strategic initiatives
                          8.3.5 AbbVie
                               8.3.5.1 Company overview
                               8.3.5.2 Financial performance
                               8.3.5.3 Product benchmarking
                               8.3.5.4 Strategic initiatives
                          8.3.6 Johnson and Johnson
                               8.3.6.1 Company overview
                               8.3.6.2 Financial overview
                               8.3.6.3 Product benchmarking
                               8.3.6.4 Strategic initiatives
                          8.3.7 Aurobindo Pharma
                               8.3.7.1 Company overview
                               8.3.7.2 Financial overview
                               8.3.7.3 Product benchmarking
                               8.3.7.4 Strategic initiatives
                          8.3.8 Mylan N.V.
                               8.3.8.1 Company overview
                               8.3.8.2 Financial overview
                               8.3.8.3 Product benchmarking
                               8.3.8.4 Strategic initiatives
                          8.3.9 Merck & Co
                               8.3.9.1 Company overview
                               8.3.9.2 Financial overview
                               8.3.9.3 Product benchmarking
                               8.3.9.4 Strategic initiatives
                          8.3.10 Cipla
                               8.3.10.1 Company overview
                               8.3.10.2 Financial overview
                               8.3.10.3 Product benchmarking
                               8.3.10.4 Strategic initiatives
                          8.3.11 Dr. Reddy's Laboratories Ltd
                               8.3.11.1 Company overview
                               8.3.11.2 Financial overview
                               8.3.11.3 Product benchmarking
                               8.3.11.4 Strategic initiatives 
List of Tables

TABLE 1 Country share estimation
TABLE 2 North America antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 3 North America antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 4 North America antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 5 U.S. antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 6 U.S. antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 7 U.S. antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 8 Canada antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 9 Canada antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 10 Canada antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 11 Europe antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 12 Europe antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 13 Europe antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 14 UK antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 15 UK antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 16 UK antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 17 Germany antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 18 Germany antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 19 Germany antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 20 Asia Pacific antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 21 Asia Pacific antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 22 Asia Pacific antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 23 Japan antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 24 Japan antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 25 Japan antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 26 China antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 27 China antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 28 China antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 29 India antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 30 India antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 31 India antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 32 Latin America antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 33 Latin America antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 34 Latin America antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 35 Brazil antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 36 Brazil antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 37 Brazil antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 38 Mexico antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 39 Mexico antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 40 Mexico antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 41 MEA antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 42 MEA antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 43 MEA antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
TABLE 44 South Africa antiviral drugs market estimates and forecasts, by mechanism of action, 2014 - 2025 (USD Billion)
TABLE 45 South Africa antiviral drugs market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
TABLE 46 South Africa antiviral drugs market estimates and forecasts, by application, 2014 - 2025 (USD Billion) 


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Global percentage of population, by age group, 2050 and 2000
FIG. 10 Market restraint relevance analysis (Current & future impact)
FIG. 11 Penetration & growth prospect mapping
FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 13 Porter's Five Forces Analysis
FIG. 14 Antiviral Drugs market mechanism of action outlook key takeaways
FIG. 15 Antiviral drugs market: Mechanism of action movement analysis
FIG. 16 Global Nucleotide polymerase inhibitor market, 2014 - 2025 (USD Billion)
FIG. 17 Global Reverse transcriptase inhibitors market, 2014 - 2025 (USD Billion)
FIG. 18 Global Protease inhibitors market, 2014 - 2025 (USD Billion)
FIG. 19 Global vaccines market, 2014 - 2025 (USD Billion)
FIG. 20 Antiviral drugs market type outlook key takeaways
FIG. 21 antiviral drugs market: Type of Manufacturer movement analysis
FIG. 22 Global Generic drugs market, 2014 - 2025 (USD Billion)
FIG. 23 Global branded drugs market, 2014 - 2025 (USD Billion)
FIG. 24 Antiviral drugs market application outlook key takeaways
FIG. 25 Antiviral drugs market: Application movement analysis
FIG. 26 Global HIV market, 2014 - 2025 (USD Billion)
FIG. 27 Global hepatitis market market, 2014 - 2025 (USD Billion)
FIG. 28 Global Herpes virus market, 2014 - 2025 (USD Billion)
FIG. 29 Global Influenza market, 2014 - 2025 (USD Billion)
FIG. 30 Global Others market, 2014 - 2025 (USD Billion)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Regional outlook, 2015 & 2024
FIG. 33 North America antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 34 U.S. antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 35 Canada antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 36 Europe antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 37 UK antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 38 Germany antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 39 Asia Pacific antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 40 Japan antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 41 China antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 42 India antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 43 Latin America antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 44 Brazil antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 45 Mexico antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 46 MEA antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 47 South Africa antiviral drugs market, 2014 - 2025 (USD Billion)
FIG. 48 Strategy framework
FIG. 49 Participant categorization

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...
Choose License Type
Single User - US $4950
Multi User - US $7950
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify